Literature DB >> 33689904

The role of Tetrahydrocannabinol in inducing disrupted signaling cascades, hippocampal atrophy and memory defects.

Elahe Barfi1, Ava Modirzadeh Tehrani2, Mojtaba Mohammadpanah1, Mahdi Eskandarian Boroujeni3, Gholam Hossein Meftahi4, Yousef Sadeghi5, Samira Eziy5, Aysan Khatmi5, Mohammad Amin Abdollahifar5, Zeynab Ghorbani6, Abbas Aliaghaei7.   

Abstract

Tetrahydrocannabinol (THC), a major psychoactive constituent of marijuana, can substantially change the function of several brain areas, leading to behavioral impairment including memory and learning dysfunction. Given the importance of hippocampus as one of the chief parts of the brain involved in memory processing, the present study seeks to investigate structural and histological alterations in hippocampus as well as behavioral defects provoked by THC treatment. Besides, using genome-wide sequencing, we adopted a pathway-based approach to discover dysregulated molecular pathways. Our results demonstrated remarkable hippocampal atrophy, and also interrupted memory function and long term potentiation (LTP) under THC exposure. We also detected several dysregulated signaling pathways involved in synaptic plasticity as well as cell-cell interaction in the hippocampus of THC-treated rats. Overall, the results indicate a potential correlation between disrupted signaling cascades, hippocampal atrophy and memory defects caused by THC treatment.
Copyright © 2021 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Hippocampus; Neurodegeneration; RNA-seq; Tetrahydrocannabinol

Year:  2021        PMID: 33689904     DOI: 10.1016/j.jchemneu.2021.101943

Source DB:  PubMed          Journal:  J Chem Neuroanat        ISSN: 0891-0618            Impact factor:   3.052


  1 in total

1.  Acute effects of Δ9-tetrahydrocannabinol and cannabidiol on auditory mismatch negativity.

Authors:  Lisa-Marie Greenwood; Samantha J Broyd; Hendrika H van Hell; Juanita Todd; Alison Jones; Robin M Murray; Rodney J Croft; Patricia T Michie; Nadia Solowij
Journal:  Psychopharmacology (Berl)       Date:  2021-11-01       Impact factor: 4.530

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.